NYSE · Healthcare Plans · USD
Humana Inc. (HUM) Stock Analysis
Humana Inc. (HUM) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
HUM Key Statistics
As of Oct 21, 2026Trading
- Open
- $431.52
- Previous Close
- $427.38
- Day's Range
- 423.85–433.47
- 52-Week Range
- 163.11–456.50
- Volume
- 1.64M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.74
Valuation
- Market Cap
- $51.08B
- P/E Ratio
- 40.21
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 24.90
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.18
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.35
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 10.58
Financials (FY)
- Revenue (FY)
- $129.66B+10.11%
- Net Income (FY)
- $1.19B−1.57%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 0.88%
- Shares Outstanding
- 120.08M
- 1-Year Return
- +45.68%
Dividend and dates
- Dividend
- $3.54+0.83%
- Ex-Dividend Date
- October 30, 2026
- Earnings Date
- November 6, 2026
- Avg Volume
- 1.32M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, HUM closed at $425.42, +45.68% over 1 year.
Humana Inc. (HUM) has a market capitalization of $51.08B.
In fiscal 2025, HUM reported revenue of $129.66B.
HUM Stock Return by Calendar Year
Humana Inc. (HUM) 10-year return: what $10,000 became
- 1 year
- $10,000 $14,568
- +45.68%
- 5 years
- $10,000 $9,688
- −3.12%
- 10 years
- $10,000 $26,282
- +162.82%
If you had invested $10,000 in Humana Inc. (HUM) 10 years ago, at the close on October 21, 2016, it would have been worth $26,282 at the close on October 21, 2026: +162.82% in total, +10.15% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +67.33% |
| 2025 | +2.36% |
| 2024 | −43.96% |
| 2023 | −9.94% |
| 2022 | +11.15% |
| 2021 | +13.80% |
| 2020 | +12.71% |
| 2019 | +28.94% |
| 2018 | +16.27% |
| 2017 | +22.60% |
| 2016 (partial year) | +15.04% |
As of October 21, 2026.
HUM Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $129.66B | $1.19B | 0.9% |
| 2024 | $117.76B | $1.21B | 1.0% |
| 2023 | $106.37B | $2.49B | 2.3% |
| 2022 | $92.87B | $2.81B | 3.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $129.66B | — | — | $1.19B | 0.9% |
| 2024 | $117.76B | — | — | $1.21B | 1.0% |
| 2023 | $106.37B | — | — | $2.49B | 2.3% |
| 2022 | $92.87B | — | — | $2.81B | 3.0% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
HUM Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.77 | 2 | — |
| 2025 | $3.54 | 4 | +0.0% |
| 2024 | $3.54 | 4 | +0.0% |
| 2023 | $3.54 | 4 | +12.3% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.77 | 2 | — |
| 2025 | $3.54 | 4 | +0.0% |
| 2024 | $3.54 | 4 | +0.0% |
| 2023 | $3.54 | 4 | +12.3% |
| 2022 | $3.15 | 4 | +12.6% |
| 2021 | $2.80 | 4 | +12.0% |
| 2020 | $2.50 | 4 | +13.6% |
| 2019 | $2.20 | 4 | +10.0% |
| 2018 | $2.00 | 4 | +5.8% |
| 2017 | $1.89 | 5 | — |
Most recent payment: $0.89 per share, ex-dividend June 26, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
HUM Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | HUM | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 40.21 | 26.38 | 52% above |
| P/S ratio | 0.35 | 0.38 | 8% below |
| Profit margin | 0.88% | 1.18% | 0.3 pts below |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
How Clinic JV Funding At Humana (HUM) Has Changed Its Investment Story
YahooHumana (HUM) Recasts CenterWell Clinics With New Joint Venture And Fresh Capital
YahooShould Value Investors Buy Humana (HUM) Stock?
YahooHumana Will Drop 37 PPOs for 2027. If Her Plan Is Discontinued, She Can Get a Medigap Window Without Health Questions Even if Humana Offers Another Advantage Plan
24/7 Wall St.Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital
YahooAngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
Yahoo
All 20 articles ↓Show fewer ↑
Humana (HUM) Will Have 95% of Its Members in Four-Star Plans, Up From 20%. What Changed?
YahooHumana (HUM) Reshapes Its Clinic Partnership, Does The Stock Look Fully Valued?
YahooHumana (HUM) Forms New Joint Venture To Fund CenterWell Clinic Growth
YahooHumana enters $2.8B primary care joint venture with BlackRock
Healthcare DiveUnitedHealth Rises 4% on Earnings Beat and Raised Full-Year Outlook; Humana Advances 2%
24/7 Wall St.Humana Forms Joint Venture With BlackRock for 150 Senior Care Clinics
YahooHumana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
YahooHumana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
BenzingaMizuho Maintains Outperform on Humana, Raises Price Target to $495
BenzingaHumana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance
BenzingaHumana Inc. to Release Third Quarter 2026 Results on November 6, 2026
YahooHumana leads Managed Care winners in new CMS Star Ratings - Evercore
YahooHumana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation?
YahooStrength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$374.30B
CVSCVS Health Corporation
$119.52B
ELVElevance Health, Inc.
$94.15B
CIThe Cigna Group
$79.88B
CNCCentene Corporation
$34.16B
MOHMolina Healthcare, Inc.
$11.22B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
MRKMerck & Co., Inc.
$369.78B
NVSNovartis AG
$292.58B














